Protocol Ledger

NCT04322318 · Phase II · RECRUITING

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Interventional Phase II clinical trial protocol NCT04322318 sponsored by Children's Oncology Group in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-10-19 Enrollment: 256 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04322318
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)256 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04322318
Protocol FieldVerified Registry Value
NCT IdentifierNCT04322318
Consolidated Lead SponsorChildren's Oncology Group
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment256 participants (ESTIMATED)
Registered Start Date2020-10-19
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI